You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, NEW ORLEANS, LA, MAY 22 TO MAY 25, 1988-Part II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Extent of Lymph Node Dissection in Melanoma of the Trunk or Lower Extremity

Daniel G. Coit, MD; Murray F. Brennan, MD

Arch Surg. 1989;124(2):162-166.


Abstract

• The extent of lymph node dissection necessary to optimize survival and minimize local recurrence in patients with melanoma of the trunk or lower extremity is not well defined. We reviewed the records of 420 patients undergoing superficial or combined superficial and deep groin dissection for melanoma. Prognosis depended on the extent of lymph node involvement rather than the extent of surgery performed. Node-positive patients undergoing elective lymph node dissection had an improved survival over those undergoing therapeutic lymph node dissection. In no subgroup of patients was more extensive lymphadenectomy associated with significant improvement in survival or alteration in pattern of recurrence. Dissection of the deep pelvic nodes in patients with melanoma appears to be of more prognostic than therapeutic value.

(Arch Surg 1989;124:162-166)



Author Affiliations

From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York.


Footnotes

Accepted for publication Aug 26, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 25, 1988.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Management of the Groin Lymph Nodes in Melanoma in the Era of Sentinel Lymph Node Dissection
Essner et al.
Arch Surg 2006;141:877-884.
ABSTRACT | FULL TEXT  

Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies
Jakub et al.
The Oncologist 2003;8:59-68.
ABSTRACT | FULL TEXT  

Cutaneous Melanoma Metastases
Lee et al.
NEJM 1998;338:922-923.
FULL TEXT  

Theoretical and Empirical Arguments in Relation to Elective Lymph Node Dissection for Melanoma
Piepkorn et al.
Arch Dermatol 1997;133:995-1002.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.